Free Trial

XTX Topco Ltd Has $358,000 Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

XTX Topco Ltd reduced its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 71.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,161 shares of the company's stock after selling 17,587 shares during the quarter. XTX Topco Ltd's holdings in Azenta were worth $358,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in AZTA. Virtu Financial LLC acquired a new stake in shares of Azenta during the third quarter worth about $352,000. Nordea Investment Management AB increased its stake in shares of Azenta by 5.7% during the fourth quarter. Nordea Investment Management AB now owns 84,804 shares of the company's stock worth $4,326,000 after acquiring an additional 4,606 shares during the period. Oak Thistle LLC purchased a new stake in shares of Azenta during the 4th quarter worth $927,000. Assenagon Asset Management S.A. acquired a new stake in shares of Azenta in the 4th quarter worth approximately $200,000. Finally, Ballentine Partners LLC increased its holdings in Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after acquiring an additional 404 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Azenta Trading Down 2.4 %

AZTA stock traded down $0.65 during trading hours on Tuesday, hitting $26.38. 77,133 shares of the stock were exchanged, compared to its average volume of 646,112. Azenta, Inc. has a 12 month low of $24.06 and a 12 month high of $63.58. The firm has a market capitalization of $1.21 billion, a P/E ratio of -8.82 and a beta of 1.66. The company has a 50-day simple moving average of $34.66 and a two-hundred day simple moving average of $43.11.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities research analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. TD Cowen upgraded Azenta to a "hold" rating in a research note on Thursday, February 27th. Stephens reaffirmed an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Needham & Company LLC raised their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Finally, Evercore ISI increased their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th.

Get Our Latest Analysis on Azenta

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines